HEADER TRANSCRIPTION 21-JAN-05 1YMT TITLE MOUSE SF-1 LBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROIDOGENIC FACTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MSF-1 LBD (RESIDUES 219-462); COMPND 5 SYNONYM: STF-1, SF-1, ADRENAL 4 BINDING PROTEIN, STEROID HORMONE COMPND 6 RECEPTOR AD4BP, FUSHI TARAZU FACTOR HOMOLOG 1, EMBRYONAL LTR BINDING COMPND 7 PROTEIN, ELP, EMBRYONAL LONG TERMINAL REPEAT- BINDING PROTEIN, COMPND 8 STEROID HYDROXYLASE POSITIVE REGULATOR; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: NUCLEAR RECEPTOR 0B2; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: MSHP PEPTIDE (RESIDUES 17-30); COMPND 15 SYNONYM: ORPHAN NUCLEAR RECEPTOR SHP, SMALL HETERODIMER PARTNER; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: NR5A1, FTZF1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: MSHP PEPTIDE, RPTILYALLSPSPR (A.A. 17-30) KEYWDS NUCLEAR RECEPTOR, SF-1, LIGAND-BINDING DOMAIN, LIGAND, PHOSPHATIDYL KEYWDS 2 GLYCEROL, CO-REPRESSOR PEPTIDE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR I.N.KRYLOVA,E.P.SABLIN,J.MOORE,R.X.XU,G.M.WAITT,D.JUZUMIENE, AUTHOR 2 J.M.BYNUM,R.J.FLETTERICK,T.M.WILLSON,H.A.INGRAHAM REVDAT 4 23-AUG-23 1YMT 1 REMARK REVDAT 3 20-OCT-21 1YMT 1 REMARK SEQADV REVDAT 2 24-FEB-09 1YMT 1 VERSN REVDAT 1 15-MAR-05 1YMT 0 JRNL AUTH I.N.KRYLOVA,E.P.SABLIN,J.MOORE,R.X.XU,G.M.WAITT,J.A.MACKAY, JRNL AUTH 2 D.JUZUMIENE,J.M.BYNUM,K.MADAUSS,V.MONTANA,L.LEBEDEVA, JRNL AUTH 3 M.SUZAWA,J.D.WILLIAMS,S.P.WILLIAMS,R.K.GUY,J.W.THORNTON, JRNL AUTH 4 R.J.FLETTERICK,T.M.WILLSON,H.A.INGRAHAM JRNL TITL STRUCTURAL ANALYSES REVEAL PHOSPHATIDYL INOSITOLS AS LIGANDS JRNL TITL 2 FOR THE NR5 ORPHAN RECEPTORS SF-1 AND LRH-1 JRNL REF CELL(CAMBRIDGE,MASS.) V. 120 343 2005 JRNL REFN ISSN 0092-8674 JRNL PMID 15707893 JRNL DOI 10.1016/J.CELL.2005.01.024 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 339886.350 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 95280 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4822 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 4 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.32 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 20170 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE : 0.3070 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1122 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.009 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1958 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 467 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.70000 REMARK 3 B22 (A**2) : 0.70000 REMARK 3 B33 (A**2) : -1.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.14 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.16 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.15 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.390 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.130 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.970 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.060 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 47.45 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : C16_1_C18_1.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : C16_1_C18_1.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1YMT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-05. REMARK 100 THE DEPOSITION ID IS D_1000031696. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03326 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 95280 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 13.10 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : 0.06100 REMARK 200 FOR THE DATA SET : 38.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1PK5 (MLRH-1 LBD) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8 MG/ML MSF-1, 6X MOLAR EXCESS OF MSHP REMARK 280 PEPTIDE, 0.1 M TRIS, 14% PEG 8000, 5% ISOPROPANOL, 15% XYLITOL, REMARK 280 PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.50700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 36.92650 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 36.92650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.25350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 36.92650 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 36.92650 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 87.76050 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 36.92650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.92650 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 29.25350 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 36.92650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.92650 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 87.76050 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.50700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: POLYPEPTIDE MONOMER (CHAIN A) BOUND TO PHOSPHOLIPID (CHAIN REMARK 300 C) REPRESENTS BIOLOGICAL ASSEMBLY REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 946 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 251 REMARK 465 PRO A 252 REMARK 465 ALA A 253 REMARK 465 LYS A 254 REMARK 465 SER A 255 REMARK 465 ARG A 256 REMARK 465 SER A 257 REMARK 465 ASP A 258 REMARK 465 LYS A 460 REMARK 465 GLN A 461 REMARK 465 THR A 462 REMARK 465 PRO B 27 REMARK 465 SER B 28 REMARK 465 PRO B 29 REMARK 465 ARG B 30 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ILE A 376 CA ILE A 376 CB 0.166 REMARK 500 SER A 431 CA SER A 431 CB -0.130 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 284 N - CA - CB ANGL. DEV. = -13.2 DEGREES REMARK 500 ASP A 310 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ARG A 314 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 LEU A 362 CA - CB - CG ANGL. DEV. = 17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 286 -60.73 70.55 REMARK 500 VAL A 286 -60.73 70.55 REMARK 500 VAL A 286 -60.73 70.55 REMARK 500 SER A 413 73.90 -104.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DR9 A 500 DBREF 1YMT A 217 462 UNP P33242 STF1_MOUSE 217 462 DBREF 1YMT B 17 30 UNP Q62227 SHP_MOUSE 17 30 SEQADV 1YMT GLY A 217 UNP P33242 CLONING ARTIFACT SEQADV 1YMT SER A 218 UNP P33242 CLONING ARTIFACT SEQADV 1YMT SER A 304 UNP P33242 CYS 302 ENGINEERED MUTATION SEQADV 1YMT SER A 408 UNP P33242 CYS 408 ENGINEERED MUTATION SEQADV 1YMT SER A 413 UNP P33242 CYS 413 ENGINEERED MUTATION SEQADV 1YMT SER A 423 UNP P33242 CYS 423 ENGINEERED MUTATION SEQRES 1 A 246 GLY SER SER GLY GLY PRO ASN VAL PRO GLU LEU ILE LEU SEQRES 2 A 246 GLN LEU LEU GLN LEU GLU PRO GLU GLU ASP GLN VAL ARG SEQRES 3 A 246 ALA ARG ILE VAL GLY CYS LEU GLN GLU PRO ALA LYS SER SEQRES 4 A 246 ARG SER ASP GLN PRO ALA PRO PHE SER LEU LEU CYS ARG SEQRES 5 A 246 MET ALA ASP GLN THR PHE ILE SER ILE VAL ASP TRP ALA SEQRES 6 A 246 ARG ARG CYS MET VAL PHE LYS GLU LEU GLU VAL ALA ASP SEQRES 7 A 246 GLN MET THR LEU LEU GLN ASN SER TRP SER GLU LEU LEU SEQRES 8 A 246 VAL LEU ASP HIS ILE TYR ARG GLN VAL GLN TYR GLY LYS SEQRES 9 A 246 GLU ASP SER ILE LEU LEU VAL THR GLY GLN GLU VAL GLU SEQRES 10 A 246 LEU SER THR VAL ALA VAL GLN ALA GLY SER LEU LEU HIS SEQRES 11 A 246 SER LEU VAL LEU ARG ALA GLN GLU LEU VAL LEU GLN LEU SEQRES 12 A 246 HIS ALA LEU GLN LEU ASP ARG GLN GLU PHE VAL CYS LEU SEQRES 13 A 246 LYS PHE LEU ILE LEU PHE SER LEU ASP VAL LYS PHE LEU SEQRES 14 A 246 ASN ASN HIS SER LEU VAL LYS ASP ALA GLN GLU LYS ALA SEQRES 15 A 246 ASN ALA ALA LEU LEU ASP TYR THR LEU SER HIS TYR PRO SEQRES 16 A 246 HIS SER GLY ASP LYS PHE GLN GLN LEU LEU LEU SER LEU SEQRES 17 A 246 VAL GLU VAL ARG ALA LEU SER MET GLN ALA LYS GLU TYR SEQRES 18 A 246 LEU TYR HIS LYS HIS LEU GLY ASN GLU MET PRO ARG ASN SEQRES 19 A 246 ASN LEU LEU ILE GLU MET LEU GLN ALA LYS GLN THR SEQRES 1 B 14 ARG PRO THR ILE LEU TYR ALA LEU LEU SER PRO SER PRO SEQRES 2 B 14 ARG HET DR9 A 500 51 HETNAM DR9 1-CIS-9-OCTADECANOYL-2-CIS-9-HEXADECANOYL PHOSPHATIDYL HETNAM 2 DR9 GLYCEROL HETSYN DR9 (2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY) HETSYN 2 DR9 PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL HETSYN 3 DR9 (9E)-OCTADEC-9-ENOATE FORMUL 3 DR9 C40 H75 O10 P FORMUL 4 HOH *467(H2 O) HELIX 1 1 PRO A 225 GLU A 235 1 11 HELIX 2 2 GLU A 237 GLN A 250 1 14 HELIX 3 3 PRO A 262 CYS A 284 1 23 HELIX 4 4 VAL A 286 LEU A 290 5 5 HELIX 5 5 GLU A 291 GLY A 319 1 29 HELIX 6 6 LEU A 334 ALA A 341 1 8 HELIX 7 7 GLY A 342 LEU A 362 1 21 HELIX 8 8 ASP A 365 PHE A 378 1 14 HELIX 9 9 ASP A 381 LEU A 385 5 5 HELIX 10 10 ASN A 387 TYR A 410 1 24 HELIX 11 11 ASP A 415 GLY A 444 1 30 HELIX 12 12 ASN A 451 ALA A 459 1 9 HELIX 13 13 THR B 19 SER B 26 1 8 SHEET 1 A 2 SER A 323 LEU A 325 0 SHEET 2 A 2 GLU A 331 GLU A 333 -1 O VAL A 332 N ILE A 324 SITE 1 AC1 20 ALA A 261 PHE A 263 LEU A 266 CYS A 267 SITE 2 AC1 20 MET A 269 ALA A 270 ARG A 283 SER A 304 SITE 3 AC1 20 LEU A 307 VAL A 337 GLN A 340 ALA A 341 SITE 4 AC1 20 GLY A 342 LEU A 345 ALA A 434 TYR A 437 SITE 5 AC1 20 LYS A 441 HOH A 571 HOH A 631 HOH A 732 CRYST1 73.853 73.853 117.014 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013540 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013540 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008546 0.00000